Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Murray

Showing results (181-190 of 207) with videos related to

Pageof 21
Sort By:
Plos Neglected Tropical Diseases|November 10, 2023
Snakebite epidemiology, outcomes and multi-cluster risk modelling in EswatiniSara Padidar, Ara Monadjem, Thea Litschka-Koen, et al.
Revista De Gastroenterologia De Mexico|August 12, 2009
[Gastroenterology diagnosis and treatment guidelines of colon and rectum carcinoma. Treatment]Luís Charúa-Guindic, Ricardo Raña-Garibay, Elena López-Gavito, et al.
Blood|February 14, 2016
EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implicationsClaire Schwab, Sarra L Ryan, Lucy Chilton, et al.
The American Journal of Tropical Medicine and Hygiene|April 15, 2025
Symptoms and Management of Painful Progressive Swelling in Eswatini Snakebite Patients: A Prospective Observational StudyJonathan Steinhorst, Thea Litschka-Koen, Bianca Ascenção, et al.
Plos Neglected Tropical Diseases|September 15, 2022
Two snakebite antivenoms have potential to reduce Eswatini's dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testingStefanie K Menzies, Thea Litschka-Koen, Rebecca J Edge, et al.
Molecular Cancer Therapeutics|October 7, 2015
Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous SystemKaren E Parrish, Ling Cen, James Murray, et al.
Scientific Reports|November 15, 2024
Downhill running does not alter blood C1q availability or complement-dependent cytotoxicity of therapeutic monoclonal antibodies against haematological cancer cell lines in vitroHarrison D Collier-Bain, Frankie F Brown, Adam J Causer, et al.
Genome Research|April 3, 2003
The first-generation whole-genome radiation hybrid map in the horse identifies conserved segments in human and mouse genomesBhanu P Chowdhary, Terje Raudsepp, Srinivas R Kata, et al.
Journal of Medicinal Chemistry|May 12, 2021
Structure-Guided Discovery of Potent and Selective DYRK1A InhibitorsCsaba Weber, Melinda Sipos, Attila Paczal, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 4, 2025
The effect of non-pharmacological interventions on cognitive function in cancer: an overview of systematic reviewsDarren Haywood, Ashley M Henneghan, Alexandre Chan, et al.
Pageof 21

Showing results (181-190 of 207) with videos related to

Sort By:
Pageof 21
Plos Neglected Tropical Diseases|November 10, 2023
Snakebite epidemiology, outcomes and multi-cluster risk modelling in EswatiniSara Padidar, Ara Monadjem, Thea Litschka-Koen, et al.
Revista De Gastroenterologia De Mexico|August 12, 2009
[Gastroenterology diagnosis and treatment guidelines of colon and rectum carcinoma. Treatment]Luís Charúa-Guindic, Ricardo Raña-Garibay, Elena López-Gavito, et al.
Blood|February 14, 2016
EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implicationsClaire Schwab, Sarra L Ryan, Lucy Chilton, et al.
The American Journal of Tropical Medicine and Hygiene|April 15, 2025
Symptoms and Management of Painful Progressive Swelling in Eswatini Snakebite Patients: A Prospective Observational StudyJonathan Steinhorst, Thea Litschka-Koen, Bianca Ascenção, et al.
Plos Neglected Tropical Diseases|September 15, 2022
Two snakebite antivenoms have potential to reduce Eswatini's dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testingStefanie K Menzies, Thea Litschka-Koen, Rebecca J Edge, et al.
Molecular Cancer Therapeutics|October 7, 2015
Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous SystemKaren E Parrish, Ling Cen, James Murray, et al.
Scientific Reports|November 15, 2024
Downhill running does not alter blood C1q availability or complement-dependent cytotoxicity of therapeutic monoclonal antibodies against haematological cancer cell lines in vitroHarrison D Collier-Bain, Frankie F Brown, Adam J Causer, et al.
Genome Research|April 3, 2003
The first-generation whole-genome radiation hybrid map in the horse identifies conserved segments in human and mouse genomesBhanu P Chowdhary, Terje Raudsepp, Srinivas R Kata, et al.
Journal of Medicinal Chemistry|May 12, 2021
Structure-Guided Discovery of Potent and Selective DYRK1A InhibitorsCsaba Weber, Melinda Sipos, Attila Paczal, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 4, 2025
The effect of non-pharmacological interventions on cognitive function in cancer: an overview of systematic reviewsDarren Haywood, Ashley M Henneghan, Alexandre Chan, et al.
Pageof 21